Literature DB >> 15152802

Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. I. Taxonomy, fermentation, isolation and screening.

Takashi Sakai1, Tomohiro Sameshima, Motoko Matsufuji, Naoto Kawamura, Kazuyuki Dobashi, Yoshiharu Mizui.   

Abstract

Seven new macrolides having a 12-membered ring, which we termed pladienolides, were isolated from the fermentation broth of Streptomyces platensis Mer-11107. Six of the seven pladienolides inhibited hypoxia-induced reporter gene expression controlled by human VEGF promoter with IC50 values of 0.0018-2.89 microM. They also demonstrated growth-inhibitory activity against U251 human glioma cells in vitro. Pladienolides are highly potent inhibitors of both hypoxia signals and cancer cell proliferation, and thus may be useful as antitumor agents.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15152802     DOI: 10.7164/antibiotics.57.173

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  33 in total

1.  Design and Synthesis of 1,2-Deoxy-pyranose Derivatives of Spliceostatin A toward Prostate Cancer Treatment.

Authors:  Yusuke Yoshikawa; Airi Ishibashi; Tsunayoshi Takehara; Takeyuki Suzuki; Kenichi Murai; Yasufumi Kaneda; Keisuke Nimura; Mitsuhiro Arisawa
Journal:  ACS Med Chem Lett       Date:  2020-05-01       Impact factor: 4.345

2.  A synthetic entry to pladienolide B and FD-895.

Authors:  Alexander L Mandel; Brian D Jones; James J La Clair; Michael D Burkart
Journal:  Bioorg Med Chem Lett       Date:  2007-07-07       Impact factor: 2.823

3.  Garbled messages and corrupted translations.

Authors:  Tilman Schneider-Poetsch; Takeo Usui; Daisuke Kaida; Minoru Yoshida
Journal:  Nat Chem Biol       Date:  2010-03       Impact factor: 15.040

4.  Structural requirements for the antiproliferative activity of pre-mRNA splicing inhibitor FR901464.

Authors:  Sami Osman; Brian J Albert; Yanping Wang; Miaosheng Li; Nancy L Czaicki; Kazunori Koide
Journal:  Chemistry       Date:  2010-11-19       Impact factor: 5.236

5.  Splice Modulation Synergizes Cell Cycle Inhibition.

Authors:  Kelsey A Trieger; James J La Clair; Michael D Burkart
Journal:  ACS Chem Biol       Date:  2020-02-17       Impact factor: 5.100

Review 6.  Therapeutic targeting of splicing in cancer.

Authors:  Stanley Chun-Wei Lee; Omar Abdel-Wahab
Journal:  Nat Med       Date:  2016-09-07       Impact factor: 53.440

7.  Design, synthesis and initial biological evaluation of a novel pladienolide analog scaffold.

Authors:  Mahesh Kumar Gundluru; Alan Pourpak; Xiaoli Cui; Stephan W Morris; Thomas R Webb
Journal:  Medchemcomm       Date:  2011-01-01       Impact factor: 3.597

8.  Enantioselective Synthesis of Spliceostatin G and Evaluation of Bioactivity of Spliceostatin G and Its Methyl Ester.

Authors:  Arun K Ghosh; Guddeti Chandrashekar Reddy; Andrew J MacRae; Melissa S Jurica
Journal:  Org Lett       Date:  2017-12-08       Impact factor: 6.005

Review 9.  Modulating splicing with small molecular inhibitors of the spliceosome.

Authors:  Kerstin A Effenberger; Veronica K Urabe; Melissa S Jurica
Journal:  Wiley Interdiscip Rev RNA       Date:  2016-07-21       Impact factor: 9.957

Review 10.  The development and application of small molecule modulators of SF3b as therapeutic agents for cancer.

Authors:  Thomas R Webb; Amanda S Joyner; Philip M Potter
Journal:  Drug Discov Today       Date:  2012-08-03       Impact factor: 7.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.